MedTrace Logo

Surveillance of Patients With Adenocarcinoma of the Gastroesophageal Junction or Esophagus

NCT02991547 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 3

Last updated 2024-02-13

No results posted yet for this study

Summary

The purpose of this study is to find out more information about patients who have cancer (adenocarcinoma) of the esophagus or gastroesophageal junction (GEJ) who have been treated with chemotherapy and radiation but have not had surgery. The study will follow patients for 5 years to monitor for their cancer and to see how the standard medical care affects the daily life of patients.

Conditions

  • Adenocarcinoma Esophagus

Interventions

OTHER

Observational

Sponsors & Collaborators

  • The Guthrie Clinic

    lead OTHER

Principal Investigators

  • Joyson Poulose, MD · Guthrie Medical Group, PC/Robert Packer Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2018-08-03
Completion
2018-08-03

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02991547 on ClinicalTrials.gov